pharma news today obesity drugs glp-1 Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Antagonists Increase Plan Drug

It is demonstrated that activity is more dependent on the variation of the substituents compared to the core

The reduction in the concentration of GSH in yeasts might have resulted in the consumption of selenium in reactions with free radicals, which are produced in excessive amounts, which was accompanied by an increase in the concentration of the oxidized form of glutathione (GSSG)

Peptide YY, release from small intestine in response to meals, signals satiety and reducing gastric motility, which slows down the emptying of the stomach

As a key downstream antioxidant enzyme of System X c /GSH/GPX4 axis, GPX4 is often used to develop ferroptosis inducers as an effective target

Kisspeptin is a neuropeptide produced by neurons in the arcuate and anteroventral periventricular nuclei of the hypothalamus